FinPharma kick-off webinar 21 October 2020
FinPharma brings together the pharmaceutical drug research of the University of Helsinki, the University of Eastern Finland, and Åbo Akademi University. FinPharma kick-off webinar on 21 October presents the new researchers and their research themes.

Come and join the FinPharma Finnish Platform for Pharmaceutical Research kick-off webinar on 21 October 2020, 13:00–16:00! In the webinar the brand new FinPharma researchers present their research subjects.

Registration is now open!

The webinar is for free.

PROGRAMME 21 October 2020 (subject to change)

13:00–13:30
Opening of the kick-off event, Jouni Hirvonen, Dean, Faculty of Pharmacy, University of Helsinki

 
Greetings from the University of Helsinki, Paula Eerola, Vice-Rector

 
Greetings from the University of Eastern Finland, Jarkko Ketolainen, Professor

 
Greetings from the Åbo Akademi University, Jessica Rosenholm, Professor

 
A brief history of FinPharma, Jari Yli-Kauhaluoma, FinPharma Director, Faculty of Pharmacy, University of Helsinki

13:30–13:50
Biologics as by-products of vascular biology research, Michael Jeltsch, Associate Professor in Pharmaceutical Protein Drug Research, University of Helsinki

13:50–14:10
Human-on-a-chip – More methodological diversity for development of medical treatments, Tiina Sikanen, Associate Professor in Pharmacometabolomics, University of Helsinki

14:10–14:30
Modulation of proteostasis as therapeutic strategy for stroke and neurodegeneration, Mikko Airavaara, Professor in Pharmacology and Drug Development, University of Helsinki

14:30–14:50
Shining a guiding light for medical Uber deliveries – Active targeting and drug release at diseased site, Tatu Lajunen, University Researcher (Targeted Delivery Technologies for Biomacromolecules), University of Helsinki & University of Eastern Finland

14:50–15:10
RNA interference and RNA activation as drug targets, Piia Kokkonen, University Researcher (Computer-aided drug design), University of Eastern Finland

15:10–15:30
Can we halt and reverse neurodegeneration? Merja Voutilainen, Assistant Professor in Regenerative Pharmacology, University of Helsinki

15:30–16:00
Closing words